In the oligosaccharide characterization territory I don't think Teva has experts like Ganesh Venkataraman and Ram Sasisekharan nor some "hidden magical" IP. I believe what Teva has done and can do is use all known techniques and tools to conducts the analysis. The one thing Roy, Jim and myself once thought could make a difference was when Teva has signed an agreement with Procognia under which Teva gained access to Procognia's proprietary glycoanalysis technology, but after digging there I've posted this isn't a possibility.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.